1. Introduction
===============

1.1. Background
---------------

The prevalence of IBS in children and adolescents is high. Various studies have reported prevalence to be approximately 8 to 12% in children, and 5 to 17% in adolescents. With this syndrome, abdominal pain, constipation, diarrhea or bloating is known to occur. ([@b1-epj-08-2719]--[@b3-epj-08-2719]). The etiology of IBS is not fully understood. But evidence suggests roles for genetic, psychosocial factors, imbalance gut microbiota, increased intestinal permeability, immune activation, and central nervous system dysfunction ([@b4-epj-08-2719]). The main strategies of management of IBS are education, modified nutrition, dietary changes, pharmacotherapy, and a bio psychosocial approach ([@b2-epj-08-2719]).

1.2. Statement of problem
-------------------------

IBS is common, but no safe and effective conventional treatment exists. Consequently, the use of herbal medicine is an interesting option in patients. Many patients use (CAM), especially when facing a chronic illness for which treatment options are limited ([@b5-epj-08-2719]). The term complementary and alternative medicine (CAM) can be defined as "a group of diverse medical and healthcare systems, practices, or products that are not generally considered part of conventional medicine" ([@b5-epj-08-2719]). Herbal medicine is a kind of therapy that utilizes medicinal plants, to prevent or cure clinical conditions ([@b6-epj-08-2719]). Herbal medicine is a frequently used as an alternative treatment modality in the world. Herbal medicine is the most common CAM used on patients with IBS. An increasing number of IBS patients are beginning to receive complementary and alternative medicines in the world, The most frequently used are herbal remedies (43%).

1.3. Objective of research
--------------------------

The aim of this study was to systematically medicines and their possible mechanisms of action in controlling IBS.

2. Material and Methods
=======================

2.1. Searched databases
-----------------------

Electronic databases including PubMed, Scopus, Cochrane library and Iranian databases SID and Magiran, were searched to access the efficacy of herbal medicines and IBS. The review was limited to studies published between 1995 and 2015. Titles, abstracts, and full texts for compliance with eligibility criteria, were reviewed.

2.2. Inclusion and exclusion criteria
-------------------------------------

Text articles in Persian, English language, literature reviews, systematic reviews and meta-analysis in IBS is inclusion criteria. The titles and abstracts of the article were evaluated. Articles with invalid reference and the lack of accurate methodology were exclusion criteria.

2.3. Quality assessment
-----------------------

Analysis and quality evaluation of the literature were performed independently by two authors. The methodological quality evaluation of randomized clinical trial was carried out using the Cochrane Collaboration tool ([@b7-epj-08-2719]). Out of 420 records found in the mentioned databases, 37 related studies were included in the final analysis ([Figure 1](#f1-epj-08-2719){ref-type="fig"}). This review has focused on the most important ancient herbal treatment: Aloe vera, Artichoke, Fumaria officinalis, Curcuma longa, Hypericum perforatum, Mentha piperita, Plantago psyllium and Melissa officinalis.

3. Results and discussion
=========================

3.1. Aloe Vera
--------------

Aloe leaves contain a transparent gel which is most commonly used as a curative effect ([@b8-epj-08-2719]). Aloe is commonly used in IBS, especially the constipation-predominant subtype ([@b9-epj-08-2719]). A randomized, double-blind, cross-over placebo controlled study evaluated aloe vera in IBS. Statistical analysis of 47 patients showed no difference between the placebo and aloe vera treatment in quality of life in IBS ([@b10-epj-08-2719]) ([Table 1](#t1-epj-08-2719){ref-type="table"}). In a previous studyby Odes et al., 35 men and women were randomized to receive capsules containing celandine-aloe vera-psyllium, or placebo, for 28 days. They reported that abdominal pain was not reduced in either group, but preparation of herbal medicine was effective as a laxative in the treatment of constipation ([@b11-epj-08-2719]). In another study by Davis et al., aloe vera had no beneficial effect in IBS symptoms ([@b12-epj-08-2719]). In an Iranian clinical study by Khedmat et al., 33 patients with constipation-predominated refractory IBS into 8 weeks, they received aloe vera (30 ml twice daily). Pain/discomfort (p \< 0.001) and flatulence decreased (p \< 0.001), Stool consistence, urgency, and frequency of defecation did not change significantly (p \> 0.5 in all) ([@b13-epj-08-2719]). In conclusion, Aloe vera can be beneficial in controlling IBS symptoms. Further placebo-controlled studies with larger patient population are needed.

3.2. Artichoke
--------------

Some documents propose that artichoke leaf extract (ALE) is useful in curing IBS. A post-marketing supervision study of ALE for 6 weeks in 279 IBS patients was done. Considerable reductions were indicated by analysis of the data in the severity of IBS symptoms. The report of 96% of patients taking ALE shows that not only does ALE act equally or better than some therapies administered for their symptoms, but also patients tolerate it well ([@b14-epj-08-2719]). In another research, the effects of ALE in 208 IBS patients with dyspepsia were investigated. After the intervention period, analysis of data showed a significant improvement in IBS occurrence of 26.4% (p \< 0.001). A significant change in self-reported usual bowel movements away from "periodic constipation/diarrhea" into "normal" (p \< 0.001) was considered. It has created a significant improvement in the total quality-of-life (QOL) score (20%) in the subset after treatment ([@b15-epj-08-2719]). The study of Emendörfer F, et al., based on the active metabolites, described the antispasmodic activity of cynaropicrin, as a sesquiterpene lactone from Cynara scolymus, in the treatment of IBS ([@b16-epj-08-2719]). These studies described that ALE has a good potential in improving the IBS symptoms.

3.3. Fumaria officinalis
------------------------

A few researches indicated that Fumaria officinalisis shows no beneficial effects in IBS. In a randomized placebo-controlled clinical trial, 106 IBS patients were divided into three treatment groups of Curcuma xanthorriza, Fumaria officinalis and placebo for 18 weeks. The pain related to IBS was reduced in the fumitory and placebo group (p=0.81). The flatulence caused by IBS had also improved in the curcuma and placebo group (p=0.48) but it had increased in fumitory group. Overall, no significant change was seen in psychological and other IBS symptoms among the three treatment groups ([@b17-epj-08-2719]). In this study, Fumaria and turmeric showed no therapeutic effects over placebo in patients with IBS. Subsequently, it is not suggested to use these herbs in the treatment of IBS.

3.4. Curcuma longa
------------------

Turmeric (Curcuma longa) has been traditionally used in Iranian and Chinese traditional medicine for digestion, abdominal pain, bloating, and distension. A pilot study, partially blinded, randomized, two-doses, of turmeric extract on IBS patients for 8 weeks, symptomology in otherwise healthy adults was done. Approximately two thirds of all subjects reported an improvement in symptoms after treatment; there were no significant differences between groups ([@b18-epj-08-2719]). Miquel J, et al. reported that curcumin has anti-inflammatory and antioxidant agents ([@b19-epj-08-2719]). In a review article by Gilani AH, et al., reported scientific basis for the medicinal use of turmeric in gastrointestinal disorders such as IBS, the data suggested that the inhibitory effects of extract of turmeric (curcumin) are mediated primarily through a calcium channel blockade in hyperactive states of the gut and airways. The efficacy of curcuma in IBS may be due to antibacterial, anti-inflammatory, and spasmolytic activities ([@b20-epj-08-2719]).

3.5. Hypericum perforatum (HP)
------------------------------

Hypericum perforatum (St. John's wort) has been effective in curing patients with mild-to-moderate depression ([@b21-epj-08-2719]). There were a few clinical trials to evaluate the beneficial effects of HP extract in IBS. A randomized, double-blind, placebo-controlled trial on 70 IBS women patients (who consumed HP) showed no significant differences between the intervention and the placebo groups ([@b22-epj-08-2719]). In contrast, a Wan H, et al. study showed that HP extract can improve the conditions of psychology and the autonomic nervous function reactivity in decreasing the stress in IBS patients ([@b21-epj-08-2719], [@b23-epj-08-2719]). Antidepressant activity and modulating psychological stress are the Hypericum perforatum mechanisms in relieving IBS ([@b23-epj-08-2719], [@b24-epj-08-2719]).

3.6. Mentha piperita( MP)
-------------------------

Mentha piperita has been used for thousands of years in Persian traditional medicine. The evidences for using MP in gastrointestinal disease are more than other herbal medicine ([@b25-epj-08-2719]). A number of controlled studies have shown that MP named enteric-coated peppermint oil is efficient in the treatment of IBS. In a randomized double-blind placebo-controlled clinical study on 110 IBS patients, peppermint-oil (three to four times daily, 15--30 min before meals, for 1 month) in comparison with placebo was evaluated. Symptom improvements were significantly higher than the placebo group (p \< 0.05). Thus, in this trial, peppermint-oil was effective and well tolerated ([@b26-epj-08-2719]). In another clinical study by Cappello et. al, (2007), 57 IBS patients were treated with peppermint oil (two enteric-coated capsules twice per day or placebo) for 4 weeks in a double blind study. They found that peppermint oil reduced significantly the total IBS symptoms score compared with the placebo group (p\<0.01). They suggested that when peppermint oil, when given for a period of 4 weeks, is safe and effective for patients with IBS ([@b27-epj-08-2719]). In a randomized double-blind placebo-controlled study by Merat et al. in 90 IBS patients Iran( 2004) that took one capsule of enteric-coated, delayed-release peppermint oil (Colpermin) or placebo three times daily for 8 weeks, they y found that the severity of abdominal pain reduced significantly in the Colpermin group as compared to controls, and Colpermin significantly improved the quality of life (p\< 0.001). There was no significant adverse reaction ([@b28-epj-08-2719]). Khanna, et al, in reviewing nine studies that evaluated efficacy and safety of enteric-coated peppermint oil capsules in 726 patients IBS has reported, peppermint oil was effective in controlling the symptoms of IBS (5 studies, 392 patients) Abdominal pain(5 studies, 357 patients) was especially significant. Adverse events of Peppermint oil, were mild and transient, the major complications were reported heartburn ([@b29-epj-08-2719]). In another review study by Grigoleit HG, et. al, similar results in 16 clinical trials investigating enteric-coated peppermint oil (PO) in IBS children were observed, but average response rates in terms of "overall success" are 58% (range 39--79%) for Peppermint oil and 29% (range 10--52%) for placebo. Adverse events reported were generally mild and transient, but very specific ([@b30-epj-08-2719]). The pharmacodynamics effect of Peppermint oil in IBS may be due to 1) reducing gastric motility, 2) antispasmodic effect on the smooth muscles due to the interference of menthol with the movement of calcium across the cell membrane, 3) anti-inflammatory and antimicrobial activities in the small intestine ([@b31-epj-08-2719]--[@b33-epj-08-2719]). Based on the researches, colpermin is safe and effective as a therapeutic method in the treatment of abdominal pain or discomfort in IBS.

3.7. Plantago psyllium
----------------------

Psyllium is mainly used as a dietary fiber, to relieve symptoms of constipation in IBS ([@b26-epj-08-2719]). In a study by Bijkerk et. al, (2009) the dietary content of soluble fiber (psyllium, 10 g, n=85), or insoluble fiber (bran, 10 g, n=97) in 275 IBS patients were evaluated. They showed those who had three months after treatment, symptom severity in the psyllium group had reduced by 90 points, compared with 58 points in the bran group. They offered that Psyllium benefits patients with IBS in primary care ([@b34-epj-08-2719]). Bijkerk (2004) et. al, in reviewing 17 articles, reported fiber reducing IBS symptoms, particularly patients with constipation, but were not effective in abdominal pain ([@b35-epj-08-2719]). In another review study by Alexander C Ford et al., similar results in six studies were observed, but when the treatment effect was considered in the meta-analysis of these studies, there was no statistical significance ([@b36-epj-08-2719]). Future clinical studies evaluating the effect and tolerability of fiber therapy are needed in primary care.

3.8. Carmint
------------

Carmint is an Iranian herbal remedy containing extracts of mentha spicata, melissa officinalis, and coriandrum sativum. An RCT in 32 patients with IBS showed that the severity and frequency of abdominal pain in the Carmint group was significantly lower than the placebo group ([@b37-epj-08-2719]). The pharmaceutical effect of Carmint is antispasmodic, carminative, and has sedative effects ([@b37-epj-08-2719]).

4. Conclusions
==============

Nowadays, IBS patients are widely used as complementary and alternative medicines; especially herbal supplements. In this article, various herbal preparations and their possible mechanisms were evaluated in the treatment of IBS. Mentha piperita plays an important role in controlling abdominal pain caused by IBS. Aloe vera, curcuma, fumaria officinalis, and hypericum perforatum showed different mechanisms such as prosecretory activity, anti-inflammatory activity and inducing gastrointestinal motility, in the management of IBS. According to various parameters that affect the pathophysiology of IBS, it is believed that compound preparations containing several herbs can be more beneficial than single products. However, different clinical trials must be done to evaluate the effects of herbal preparations in IBS.
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Herbs used for treatment of irritable bowel syndrome

  Herbal medicine                                                     Part                                                                      Type of study                                                                                                       Model                                                                     Results                                                                                                                    Ref. no.
  ------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- --------------------
  Aloe Vera                                                           Gel                                                                       Cross-over, placebo-RCT                                                                                             IBS patients                                                              No difference between treatment and placebo groups                                                                         [@b10-epj-08-2719]
  A double-blind RCT                                                  IBS patients constipation                                                 Effective in constipation, No effect on abdominal pain.                                                             [@b11-epj-08-2719]                                                                                                                                                                                   
  Double-blind placebo-RCT                                            IBS patients                                                              No difference between treatment and placebo groups                                                                  [@b12-epj-08-2719]                                                                                                                                                                                   
  Artichoke                                                           Whole plant                                                               Post-marketing surveillance study                                                                                   IBS patients                                                              Significant reductions in the severity of symptoms                                                                         [@b15-epj-08-2719]
  Open dose-ranging study                                             IBS patients                                                              "Alternating constipation/diarrhea" toward "normal", significant improvement in total quality-of-life (QOL) score   [@b16-epj-08-2719]                                                                                                                                                                                   
  Fumaria officinalis                                                 Whole plant                                                               Double-blind, placebo-RCT                                                                                           IBS patients                                                              No difference between treatment and placebo groups                                                                         [@b18-epj-08-2719]
  Curcuma longa                                                       Rhizome                                                                   Pilot study, partially blinded, RCT randomized,                                                                     IBS patients                                                              No difference between treatment and placebo groups                                                                         [@b19-epj-08-2719]
  Hypericum perforatum (HP)                                           Aerial parts                                                              Open-label, uncontrolled trial                                                                                      IBS patients women                                                        Autonomic nervous system to different stressor, improvement of Gastrointestinal symptoms of IBS                            [@b22-epj-08-2719]
  Double-blind, placebo-RCT                                           IBS patients                                                              No difference between treatment and placebo groups                                                                  [@b23-epj-08-2719]                                                                                                                                                                                   
  Mentha piperita (MP)                                                Essence                                                                   Double-blind, placebo-RCT                                                                                           IBS patients                                                              Peppermint-oil was effective and well tolerated                                                                            [@b27-epj-08-2719]
  Oil                                                                 Prospective double-blind, placebo-RCT                                     IBS patients                                                                                                        Improves abdominal symptoms                                               [@b28-epj-08-2719]                                                                                                         
  Oil                                                                 Double-blind, placebo-RCT                                                 IBS patients                                                                                                        Significantly improved the quality of life, improves abdominal symptoms   [@b29-epj-08-2719]                                                                                                         
  Plantago psyllium                                                   Seed                                                                      Placebo, RCT                                                                                                        IBS patients constipation                                                 Decrease Symptom severity significantly in the psyllium group, no differences in QOL                                       [@b35-epj-08-2719]
  Carmint (Mentha spicata, Melissa officinalis, Coriandrum sativum)   Mentha piperita, Melissa officinalis (leaf), Coriandrum sativum (fruit)   Double-blind, placebo-RCT                                                                                           IBS patients                                                              Severity and frequency of abdominal pain/discomfort were significantly lower in the Carmint group than the placebo group   38
